Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) have seen a consistent move higher lately. The stock has reached the $28.01 mark after a recent check. This move has generated increased interest from both analysts and investors.Since the start of the calendar year, Myriad Genetics, Inc. (NASDAQ:MYGN)’s stock has changed 67.85%. Over the last five trading sessions, the stock has moved 16.53%. For the past month, Myriad Genetics, Inc.’s stock has been 10.81%, 23.15% for the last quarter, 69.37% for the past six months and -5.02% for the past 52 weeks.
Based on current stock levels, Myriad Genetics, Inc. shares are trading -0.59% off of the 50-day high and 41.85% away from the 50-day low.
Myriad Genetics, Inc. (NASDAQ:MYGN)’s EPS growth this year is 58.60% and the trailing 12-month EPS is $0.61. Covering sell-side analysts are estimating company growth for next year to be 6.73%. On a consensus basis, analysts have given a recommendation of 3.00 on company shares.